EN
HI
Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
63.63 L
Market Cap
9864.46 CR
LTQ@LTP
25@217.62
ATP
214.62
Var Margin
20.84 %
Circuit Range
165.96-248.94
Delivery %
33.59 %
Value
136.57 CR
ASM/GSM
No
Market Lot
1
Summary
Marksans Pharma share price is ₹217.62 as of 19 May, 2026. The stock Marksans Pharma intraday movement has stayed between ₹208.10 and ₹219.30, while on a 52-week basis,Marksans Pharma price 52 week high is ₹270.70 & its 52 week low is ₹155.00.
In terms of trading activity, Marksans Pharma has recorded a volume of 6363446 shares, The Marksans Pharma has a market cap of ₹453288438 CR. The stock’s Average Traded Price (ATP) stands at ₹214.62, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 25 @ ₹217.62.
Marksans Pharma operates within a circuit range of ₹165.96 – ₹248.94, with a Value of ₹136.57 CR. The Delivery Percentage for the day is 33.59%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
View MoreP/E Ratio
26.12
P/B Ratio
3.36
Div. Yield
0.39
Sector P/E
71.32
Sector P/B
3.45
Sec. Div. Yield
0.56
Marksans Pharma Resistance and Support
Pivot 206.98
Resistance
First Resistance
213.91
Second Resistance
220.38
Third Resistance
227.31
Support
First Support
200.51
Second Support
193.58
Third Support
187.11
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results And To Consider Recommendation Of Dividend If Any, For The Financial Year Ended March 31, 2026
Marksans Pharma will convene a board meeting on May 26, 2026. The agenda includes the consideration and approval of audited financial results for the quarter and year ended March 31, 2026, and a recommendation for dividend.
May 12 2026 15:05:00
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
CORONA Remedies Ltd.
1820.20
42.90 (2.41%)
Strides Pharma Science Ltd.
1151.40
-2.30 (0.20%)
Park Medi World Ltd.
239.75
-4.71 (1.93%)
Viyash Scientific Ltd.
225.48
0.94 (0.42%)
Healthcare Global Enterprises Ltd.
632.25
-4.95 (0.78%)
Shilpa Medicare Ltd.
476.20
-2.20 (0.46%)
Jupiter Life Line Hospitals Ltd.
1338.00
11.50 (0.87%)
Procter & Gamble Health Ltd.
5255.00
-45.00 (0.85%)
Akums Drugs & Pharmaceuticals Ltd.
519.75
2.80 (0.54%)
Yatharth Hospital & Trauma Care Services Ltd.
808.50
-7.10 (0.87%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 217.62 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 26.12. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 3.36. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 71.32 & 3.45 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 9864.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 270.70 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
